Kai Schulze Selected Research

cyclic diadenosine phosphate

1/2020	Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi.
1/2019	The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells.
10/2017	Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in mice.
1/2017	Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice.
1/2017	Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection.
1/2017	Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi.
1/2014	Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kai Schulze Research Topics

Disease

11	Infections 01/2022 - 12/2003
4	Bites and Stings (Sting) 01/2020 - 01/2017
4	Human Influenza (Influenza) 01/2019 - 01/2014
3	Neoplasms (Cancer) 01/2017 - 08/2007
2	Communicable Diseases (Infectious Diseases) 01/2019 - 01/2015
2	Streptococcal Infections (Streptococcal Infection) 09/2010 - 08/2006
1	Malaria 01/2022
1	Body Weight (Weight, Body) 06/2021
1	COVID-19 04/2021
1	Thrombocytopenia (Thrombopenia) 10/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2020
1	Persistent Infection 01/2020
1	Parasitic Diseases (Parasitic Disease) 01/2020
1	Diphtheria 01/2019
1	Tetanus 01/2019
1	Inflammation (Inflammations) 01/2017
1	Chagas Disease (American Trypanosomiasis) 01/2017
1	Weight Loss (Weight Reduction) 01/2017
1	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 01/2017
1	Parasitemia 01/2017
1	Polyploidy 09/2016
1	Migraine Disorders (Migraine) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Sepsis (Septicemia) 09/2010

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 01/2022 - 09/2010
7	cyclic diadenosine phosphateIBA 01/2020 - 01/2014
4	Adenosine Monophosphate (AMP)IBA 01/2019 - 01/2014
4	AntigensIBA 01/2019 - 09/2010
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2003
2	VirosomesIBA 01/2022 - 01/2017
2	Peptides (Polypeptides)IBA 10/2017 - 08/2006
1	AntioxidantsIBA 01/2022
1	Malaria VaccinesIBA 01/2022
1	Subunit VaccinesIBA 06/2021
1	CytokinesIBA 06/2021
1	Pharmaceutical PreparationsIBA 04/2021
1	SaltsIBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	aluminum sulfate (alum)IBA 01/2019
1	AluminumIBA 01/2019
1	LigandsIBA 01/2019
1	Poly I-CIBA 01/2019
1	Protein Subunit VaccinesIBA 11/2017
1	OvalbuminIBA 10/2017
1	Galactosylceramides (Galactocerebrosides)IBA 01/2017
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2017
1	InterferonsIBA 01/2017
1	NucleotidesIBA 01/2017
1	OligodeoxyribonucleotidesIBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 09/2016
1	FlunarizineIBA 01/2016
1	Antiviral Agents (Antivirals)IBA 01/2016
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2016
1	Pimozide (Orap)FDA Link 01/2016
1	PhenothiazinesIBA 01/2016
1	NucleoproteinsIBA 01/2014
1	AntibodiesIBA 09/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2010
1	opacity factorIBA 03/2008
1	alpha-galactosylceramideIBA 08/2007
1	GlycolipidsIBA 08/2007
1	Conjugate VaccinesIBA 08/2006
1	Fibronectins (Fibronectin)IBA 12/2003

Therapy/Procedure

3	Therapeutics 03/2020 - 01/2016
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2020
1	Mucosal Administration 01/2017